-
Signature
-
/s/ William Cook, as Attorney-in-fact for David Scadden
-
Stock symbol
-
AGIO
-
Transactions as of
-
Nov 12, 2025
-
Transactions value $
-
-$5,150
-
Form type
-
4
-
Date filed
-
11/14/2025, 04:04 PM
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Scadden David |
Director |
C/O AGIOS PHARMACEUTICALS, INC., 88 SIDNEY STREET, CAMBRIDGE |
/s/ William Cook, as Attorney-in-fact for David Scadden |
2025-11-14 |
0001707715 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
AGIO |
Common stock |
Options Exercise |
$3.62K |
+200 |
+1.14% |
$18.09 |
17.8K |
Nov 12, 2025 |
Direct |
F1 |
| transaction |
AGIO |
Common stock |
Sale |
-$8.77K |
-200 |
-1.12% |
$43.84 |
17.6K |
Nov 12, 2025 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
AGIO |
Stock options (right to buy) |
Options Exercise |
$0 |
-200 |
-0.74% |
$0.00 |
26.9K |
Nov 12, 2025 |
Common stock |
200 |
$18.09 |
Direct |
F1, F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: